Ronald Muhlenkamp - Muhlenkamp & Co 13F Activity & Position Changes (Q2 2018)

According to the SEC 13F filed on Aug 18, 2026, the Muhlenkamp & Co portfolio showed several notable changes in holdings as of quarter-end Jun 30, 2018. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2018, the filing reported:

New Buys - Invesco BuyBack Achievers ETF

Increases - Pfizer, Inc.

Reductions - Bread Financial Holdings, Inc., Delta Air Lines, Inc., Gilead Sciences, Inc., ON Semiconductor Corporation

Complete Exits - Bristol-Myers Squibb Company

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q2 2018	BFH Bread Financial Holdings, Inc.	Bread Financial Holdings, Inc.	Sell	-10	-0.0%	$16.45K	70,519
Q2 2018	BMY Bristol-Myers Squibb Company	Bristol-Myers Squibb Company	Sell - Position Exit	-178,436	-100.0%	$0.00	-
Q2 2018	DAL Delta Air Lines, Inc.	Delta Air Lines, Inc.	Sell	-55	-0.0%	$5.71K	115,308
Q2 2018	GILD Gilead Sciences, Inc.	Gilead Sciences, Inc.	Sell	-86,153	-38.7%	$9.65K	136,224
Q2 2018	ON ON Semiconductor Corporation	ON Semiconductor Corporation	Sell	-172,948	-24.4%	$11.93K	536,518
Q2 2018	PFE Pfizer, Inc.	Pfizer, Inc.	Buy	+246	+0.9%	$997.00	27,485
Q2 2018	PKW Invesco BuyBack Achievers ETF	Invesco BuyBack Achievers ETF	Buy - Position Entry	+36,381	-	$2.06K	36,381